![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](cs2049contents.gif)
Acta Cryst. (2007). E63, o3938 [ doi:10.1107/S1600536807041803 ]
Abstract: The title compound, C8H17NO2·C8H8O3, exists as a complex with the base (pregabalin) in the predicted zwitterion form, based on the pKa differences between the acid and base. The asymmetric unit consists of two molecules of each component. The -NH3 group adopts the standard propeller conformation. The structure forms pairs of hydrophobic and hydrophilic interactions along both the a and c axes.
Online 1 September 2007
Copyright © International Union of Crystallography
IUCr Webmaster